Qin Xie
Direktor/Vorstandsmitglied bei CUTIA THERAPEUTICS
Profil
Qin Xie is currently a Director at Cutia Therapeutics (Shanghai) Co., Ltd.
and a Non-Executive Director at Cutia Therapeutics.
Previously, Dr. Xie held positions as a Managing Director at Frontline Bioventures, a Senior Investment Manager at Shanghai Pharmaceuticals Holding Co., Ltd., a Manager-Business Development at Hisun Pfizer Pharmaceuticals Co., Ltd., and a Member-Supervisory Board at Ocumension Therapeutics.
Dr. Xie completed a graduate degree at the University of Oxford in 2004, a doctorate degree at the University of Oxford in 2011, and an undergraduate degree at Xi'an Jiaotong University in 2003.
Aktive Positionen von Qin Xie
| Unternehmen | Position | Beginn |
|---|---|---|
| CUTIA THERAPEUTICS | Direktor/Vorstandsmitglied | 23.08.2019 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Qin Xie
| Unternehmen | Position | Ende |
|---|---|---|
Hisun Pfizer Pharmaceuticals Co., Ltd.
 Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Corporate Officer/Principal | 01.12.2015 |
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Chief Investment Officer | 01.12.2012 |
| Frontline Bioventures | Vorstandsvorsitzender | - |
| OCUMENSION THERAPEUTICS | Direktor/Vorstandsmitglied | - |
Ausbildung von Qin Xie
| University of Oxford | Doctorate Degree |
| Xi'an Jiaotong University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| OCUMENSION THERAPEUTICS | Health Technology |
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Health Technology |
| CUTIA THERAPEUTICS | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Frontline Bioventures | Finance |
Hisun Pfizer Pharmaceuticals Co., Ltd.
Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Health Technology |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang. | Health Technology |
